| # | Drug | Count |
|---|---|---|
| 0 | OXALIPLATIN | 33 |
| 1 | ACETAMINOPHEN | 30 |
| 2 | ANAKINRA | 30 |
| 3 | CETIRIZINE | 30 |
| 4 | CETIRIZINE HYDROCHLORIDE | 30 |
| 5 | DEXAMETHASONE | 30 |
| 6 | DEXAMETHASONE 1.5 MG | 30 |
| 7 | FAMOTIDINE | 30 |
| 8 | FLUOROURACIL | 30 |
| 9 | FLUOROURACIL CREAM, 0.5% | 30 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ANAKINRA | 30 | 0.0018 |
| 1 | LEUCOVORIN CALCIUM | 19 | 0.0010 |
| 2 | CETIRIZINE HYDROCHLORIDE TABLETS | 22 | 0.0007 |
| 3 | OXALIPLATIN | 33 | 0.0004 |
| 4 | FLUOROURACIL CREAM, 0.5% | 30 | 0.0004 |
| 5 | SODIUM CHLORIDE TABLET | 29 | 0.0004 |
| 6 | SODIUM CHLORIDE TABLETS | 29 | 0.0004 |
| 7 | FLUOROURACIL | 30 | 0.0004 |
| 8 | SODIUM CHLORIDE | 30 | 0.0004 |
| 9 | ACETAMINOPHEN AND DIPHENHYDRAMINE HCL | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-1 Receptor Antagonist [EPC] | 30 | 0.0018 |
| 1 | Histamine-2 Receptor Antagonist [EPC] | 30 | 0.0002 |
| 2 | Serotonin-3 Receptor Antagonist [EPC] | 30 | 0.0002 |
| 3 | Platinum-based Drug [EPC] | 33 | 0.0001 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 30 | 0.0001 |
| 5 | Osmotic Laxative [EPC] | 29 | 0.0001 |
| 6 | Histamine-1 Receptor Antagonist [EPC] | 8 | 0.0001 |
| 7 | Leukotriene Receptor Antagonist [EPC] | 1 | 0.0000 |
| 8 | Corticosteroid [EPC] | 30 | 0.0000 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 30 | 0.0000 |